Find a Physician | How to Contribute | Contact Us | Clinical Trials
Search: 
Select a Cancer Type:

Cancer is Colorblind

Cancer is Colorblind (CiC) seeks to raise awareness and funds for pediatric and adult cancer prevention and treatment, while honoring cancer survivors and fighters who have made an impact in the local community. Launched in January 2011, the campaign has already experienced a significant outpouring of support through the Chicago City Challenge and the “Race Against Cancer� 5K Run/Walk at Soldier Field. Several sponsors including KPMG, Dominick’s, Doubletree, Patel Brothers, Haymarket Brewery and Pub, and Race Time have generously supported the campaign with monetary and in-kind donations. Proceeds from November’s Cancer is Colorblind Charity Gala will add to the campaign.

All CiC proceeds benefit oncology programs at two Chicago cancer institutions, which serve diverse communities and patient populations: Bear Necessities Pediatric Cancer Foundation and the Robert H Lurie Comprehensive Cancer Center of Northwestern University.

CiC is supporting cancer research at the Lurie Cancer Center focused on developing the first patient-centered cancer care model in Chicago. Lurie Cancer Center scientists are developing therapies based on a person’s singular genetic makeup and the genetic makeup of the disease. The promise of such personalized medicine is that by customizing treatment strategies to each patient’s needs, treatment will be more effective and cause fewer side effects. Because lung cancer is the most common cancer-related cause of death among American men and women, all of the funds donated by CiC will be used to advance treatments focused on improving mortality rates for lung and thoracic cancers.